bupropion and tirzepatide Obesity drugs under review: Semaglutide, tirzepatide, naltrexone/bupropion all boost heart health What is the recommended protocol

A bipartisan coalition of 38 state Attorneys General have called on the FDA to take swift action against compounding pharmacies that "cut corners in pursuit of a quick profit" and sell knockoff drugs that could lead to "serious public health issues." The Ohio Attorney General recently issued a press release about letters it sent to 14 entities warning them to stop deceiving patients into believing that compounded drugs are approved by the FDA or have been reviewed for safety, effectiveness, or quality and declaring that patients "deserve clear and accurate information about the medication they're putting in their bodies." Similarly, in December 2024, the Illinois Attorney General issued cease-and-desist letters to five Chicagoland med spas advertising name brand medications like Wegovy and Ozempic but "instead offering unapproved versions of these products that may put people's health at risk." In addition, over a dozen Attorneys General have issued statements discussing the dangers posed by knockoff "semaglutide," including North Carolina, South Carolina, and Tennessee

Tirzepatide dosing chart The tirzepatide dosing schedule is ultimately set by your healthcare provider, but Eli Lilly (the manufacturer of both Mounjaro and Zepbound) has designed a tirzepatide dosing chart that most providers will follow

mTOR activation increases ribosomal activity and enhances structural protein assembly within muscle fibers

Just clear instructions from real medical professionals

Graphical abstract Suspected clinical impacts of GLP-1RAs, SGLT2is, and finerenone oncardiovascular and kidney outcomes